EMAIL THIS PAGE TO A FRIEND

Cancer Letters

A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo.


PMID 25524552

Abstract

We're sorry this abstract is currently not available.